Tuberculosis
896
67
91
603
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
131 trials with published results (15%)
Research Maturity
603 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.7%
33 terminated out of 896 trials
94.8%
+8.2% vs benchmark
14%
122 trials in Phase 3/4
22%
131 of 603 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 603 completed trials
Clinical Trials (896)
Linezolid Dosing Strategies in Drug-Resistant TB
A Study to Investigate the Repeat-dose Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With Ganfeborole in Female Participants of Non-childbearing Potential
Systems Analysis and Improvement Approach to Prevent TB
Re-evaluating the Duration in Children of TB Treatment
Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis
Evaluation and Demonstration of New Tuberculosis Diagnostics for Indonesia
Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children (TB-Speed HIV)
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals
A Clinical Study of the HCMV-TB Vaccine Candidate VIR-1778 in Healthy Adults
Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
South Africa Smoking Cessation and Engagement in HIV/TB Care Care
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial
Assessing Diagnostics At Point-of-care for Tuberculosis
Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)
Training Protocol on the Natural History of Tuberculosis
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis